Literature DB >> 2803932

Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypes.

R S du Toit1, A P Locker, I O Ellis, C W Elston, R I Nicholson, R W Blamey.   

Abstract

One hundred and seventy-one cases of operable invasive lobular carcinoma, presenting over an 11-year period, were reviewed. Histological subtypes were investigated to determine differences in their clinical behaviour and whether these differences could be explained by histopathological features. Five subtypes were identified: mixed (45.6%), classical (30.4%), tubulo-lobular (13.5%), solid (6.4%) and alveolar (4.1%). The median follow-up period was 64 months and the median age 54 years. The 12-year actuarial survival rate was 100% for the tubulo-lobular subtype, but only 47% for the solid variant. Similar differences were found in the disease free interval, locoregional and distant metastatic rates between these two subtypes. The tubulo-lobular tumours were more likely to be of good histological grade and node negative. The other three subtypes did not differ significantly in their histopathological parameters, reflected in similar clinical behaviour. They occupied an intermediate position between the other two subtypes in terms of prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2803932      PMCID: PMC2247102          DOI: 10.1038/bjc.1989.323

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Histologic variants of infiltrating lobular carcinoma of the breast.

Authors:  R E Fechner
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

2.  Steroid receptors in early breast cancer: value in prognosis.

Authors:  R I Nicholson; F C Campbell; R W Blamey; C W Elston; D George; K Griffiths
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

3.  Signet-ring cell carcinoma of the breast. The mucinous variant of infiltrating lobular carcinoma?

Authors:  J S Steinbrecher; S G Silverberg
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

4.  Tubulolobular invasive breast cancer: a variant of lobular invasive cancer.

Authors:  E R Fisher; R M Gregorio; C Redmond; B Fisher
Journal:  Hum Pathol       Date:  1977-11       Impact factor: 3.466

5.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

6.  Invasive lobular carcinoma of the breast: incidence and variants.

Authors:  V Martinez; J G Azzopardi
Journal:  Histopathology       Date:  1979-11       Impact factor: 5.087

7.  Long-term survivors after breast cancer.

Authors:  J M Dixon; D L Page; T J Anderson; D Lee; R A Elton; H J Stewart; A P Forrest
Journal:  Br J Surg       Date:  1985-06       Impact factor: 6.939

8.  Alveolar variant of invasive lobular carcinoma of the breast. A tumor rich in estrogen receptors.

Authors:  S Shousha; C M Backhous; J Alaghband-Zadeh; I Burn
Journal:  Am J Clin Pathol       Date:  1986-01       Impact factor: 2.493

Review 9.  Lobular carcinoma of the breast in situ and infiltrating.

Authors:  J E Wheeler; H T Enterline
Journal:  Pathol Annu       Date:  1976

10.  Infiltrating lobular carcinoma of the breast.

Authors:  J M Dixon; T J Anderson; D L Page; D Lee; S W Duffy
Journal:  Histopathology       Date:  1982-03       Impact factor: 5.087

  10 in total
  14 in total

1.  Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.

Authors:  Audree B Tadros; Hannah Y Wen; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2018-08-09       Impact factor: 5.344

2.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

3.  Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls.

Authors:  Evan A Farkash; Judith A Ferry; Nancy Lee Harris; Ephraim P Hochberg; Ronald W Takvorian; Dan S Zuckerman; Aliyah R Sohani
Journal:  J Hematop       Date:  2009-08-20       Impact factor: 0.196

4.  Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study.

Authors:  Ju-Hyun Lee; Seho Park; Hyung Seok Park; Byeong-Woo Park
Journal:  World J Surg Oncol       Date:  2010-04-27       Impact factor: 2.754

Review 5.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma.

Authors:  Jean-Christophe Tille; André F Vieira; Caroline Saint-Martin; Lounes Djerroudi; Laëtitia Furhmann; Francois-Clement Bidard; Youlia Kirova; Anne Tardivon; Fabien Reyal; Matthieu Carton; Anne Vincent-Salomon
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

7.  Comparison of the subgross distribution of the lesions in invasive ductal and lobular carcinomas of the breast: a large-format histology study.

Authors:  Syster Hofmeyer; Gyula Pekár; Mária Gere; Miklós Tarján; Dan Hellberg; Tibor Tot
Journal:  Int J Breast Cancer       Date:  2012-10-14

8.  Invasive lobular carcinoma arising in accessory breast tissue.

Authors:  Catriona Devine; Carol-Ann Courtney; Rahul Deb; Amit Agrawal
Journal:  World J Surg Oncol       Date:  2013-02-26       Impact factor: 2.754

9.  DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

Authors:  H Beerman; B A Bonsing; M J van de Vijver; J Hermans; P M Kluin; R J Caspers; C J van de Velde; C J Cornelisse
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Authors:  Grazia Arpino; Valerie J Bardou; Gary M Clark; Richard M Elledge
Journal:  Breast Cancer Res       Date:  2004-02-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.